Interaction of aging and Immunosenescence : New therapeutic targets of aging
Copyright © 2022 Elsevier B.V. All rights reserved..
Aging is a natural physiological process, but aging can increase the prevalence and mortality of chronic diseases in the elderly. It involves multiple organs and systems, and an essential aspect of aging is immunosenescence. With the increase of age, the immune system has undergone a series of changes and disorders. These changes have led to a decline in the resistance of the elderly to infection, reduced immunity to vaccines, increased incidence of cancer and autoimmune diseases, and an increased structural prevalence of low-grade inflammation. Moreover, affecting the aging process to a certain extent. This review introduces the changes in the immune system during aging and discusses the consequences and effects of these changes. And its effect on the aging process and the methods and ways of anti-aging were discussed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:113 |
---|---|
Enthalten in: |
International immunopharmacology - 113(2022), Pt A vom: 01. Dez., Seite 109397 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liao, Shuxian [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adaptive immune |
---|
Anmerkungen: |
Date Completed 06.12.2022 Date Revised 06.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.intimp.2022.109397 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349741468 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349741468 | ||
003 | DE-627 | ||
005 | 20231226043341.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.intimp.2022.109397 |2 doi | |
028 | 5 | 2 | |a pubmed24n1165.xml |
035 | |a (DE-627)NLM349741468 | ||
035 | |a (NLM)36461596 | ||
035 | |a (PII)S1567-5769(22)00881-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liao, Shuxian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Interaction of aging and Immunosenescence |b New therapeutic targets of aging |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2022 | ||
500 | |a Date Revised 06.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
520 | |a Aging is a natural physiological process, but aging can increase the prevalence and mortality of chronic diseases in the elderly. It involves multiple organs and systems, and an essential aspect of aging is immunosenescence. With the increase of age, the immune system has undergone a series of changes and disorders. These changes have led to a decline in the resistance of the elderly to infection, reduced immunity to vaccines, increased incidence of cancer and autoimmune diseases, and an increased structural prevalence of low-grade inflammation. Moreover, affecting the aging process to a certain extent. This review introduces the changes in the immune system during aging and discusses the consequences and effects of these changes. And its effect on the aging process and the methods and ways of anti-aging were discussed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Adaptive immune | |
650 | 4 | |a Aging | |
650 | 4 | |a Immunosenescence | |
650 | 4 | |a Innate immune | |
700 | 1 | |a Ning, Qian |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yao |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Xuhong |e verfasserin |4 aut | |
700 | 1 | |a Tang, Shengsong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 113(2022), Pt A vom: 01. Dez., Seite 109397 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
773 | 1 | 8 | |g volume:113 |g year:2022 |g number:Pt A |g day:01 |g month:12 |g pages:109397 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2022.109397 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 113 |j 2022 |e Pt A |b 01 |c 12 |h 109397 |